Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial

Author(s):
Schiff, M.; Weinblatt, M.E.; Valente, R.; Heijde, D. van der; Citera, G.; Elegbe, A.; Maldonado, M.; Fleischmann, R.
Published
2014
Publication type
Article / Letter to editor
Rheumatoid ArthritisDMARDs (Biologic)Methotrexate
Date issued
2014-01-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, no. 1, p. 86-94
hdl
1887/103660
doi
10.1136/annrheumdis-2013-203843